Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

2.2K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.2K
Inflammation01:38

Inflammation

46.0K
Overview
46.0K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

1.0K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

634
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
634
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

818
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
818
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

653
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
653

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Secretoneurin as a novel predictor of metabolic syndrome in patients with obstructive sleep apnea syndrome.

Brazilian journal of otorhinolaryngology·2026
Same author

Assessment of serum alarin levels in pregnancies complicated with gestational diabetes mellitus.

Ginekologia polska·2026
Same author

Suspicious bands in serum and urine protein immunofixation electrophoresis tests in patients with and without a history of monoclonal gammopathies: a retrospective database study.

Laboratory medicine·2026
Same author

Thermal stresses in SOFC stacks: the role of mismatch among thermal conductivity of adjacent components.

Turkish journal of chemistry·2026
Same author

Defining the postoperative alpha angle threshold for improved outcomes in posterolateral cam lesions.

Hip international : the journal of clinical and experimental research on hip pathology and therapy·2026
Same author

Altered vaspin levels in hypothyroid patients: A potential marker of metabolic dysregulation.

Medicine·2026

Related Experiment Video

Updated: Apr 23, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.0K

HDL functionality and crystal-based sterile inflammation in atherosclerosis.

Esin Eren1, Hamit Yasar Ellidag2, Ozgur Aydin3

  • 1Atatürk Hospital, Biochemistry Laboratory, Antalya, Turkey.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|October 4, 2014
PubMed
Summary

Inflammation, driven by sterile crystals from excessive nutrient intake, may link to atherosclerosis and impact high-density lipoprotein (HDL) function. This review explores the connection between crystal-induced inflammation and HDL functionality.

Keywords:
Cholesterol crystallineHDL dysfunctionInflammasomeParaoxonaseSterile inflammationUric acid crystalline

More Related Videos

A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium
11:00

A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium

Published on: June 22, 2010

28.8K
Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice
07:51

Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice

Published on: January 13, 2012

19.9K

Related Experiment Videos

Last Updated: Apr 23, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.0K
A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium
11:00

A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium

Published on: June 22, 2010

28.8K
Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice
07:51

Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice

Published on: January 13, 2012

19.9K

Area of Science:

  • Immunology
  • Metabolic Diseases
  • Evolutionary Biology

Background:

  • Organisms historically used inflammatory pathways for survival against pathogens and tissue damage.
  • Modern diseases like atherosclerosis are increasingly linked to chronic inflammation.
  • Excessive nutrient intake can lead to endogenous crystal formation, triggering sterile inflammation.

Purpose of the Study:

  • To evaluate the relationship between crystal-induced sterile inflammation and high-density lipoprotein (HDL) functionality.
  • To explore the role of HDL in managing sterile inflammatory responses.

Main Methods:

  • Literature review of studies on sterile inflammation, crystal formation, and HDL function.
  • Analysis of mechanisms linking metabolic dysregulation to immune responses.
  • Synthesis of current understanding of HDL's role in atherosclerosis and inflammation.

Main Results:

  • Excessive intake of glucose, lipids, and proteins can form endogenous crystals (e.g., cholesterol).
  • These crystals can induce a sterile inflammatory immune response, creating a detrimental cycle.
  • This sterile inflammation may be associated with impaired high-density lipoprotein (HDL) functionality.

Conclusions:

  • Crystal-induced sterile inflammation is a potential factor in diseases like atherosclerosis.
  • Understanding the interplay between crystal-induced inflammation and HDL functionality is crucial for developing new therapeutic strategies.
  • Further research is needed to elucidate the precise mechanisms and clinical implications.